BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10706856)

  • 21. Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
    Kröger N; Schilling G; Einsele H; Liebisch P; Shimoni A; Nagler A; Perez-Simon JA; San Miguel JF; Kiehl M; Fauser A; Schwerdtfeger R; Wandt H; Sayer HG; Myint H; Klingemann H; Zabelina T; Dierlamm J; Hinke A; Zander AR
    Blood; 2004 Jun; 103(11):4056-61. PubMed ID: 14982868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of chromosome 13 (13q14) deletion among Sudanese patients with multiple myeloma using a molecular genetics fluorescent in situ hybridization technique (FISH).
    Dowd AA; Homeida S; Elkarem HA
    Malays J Pathol; 2015 Aug; 37(2):95-100. PubMed ID: 26277665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13.
    Avet-Louseau H; Daviet A; Sauner S; Bataille R;
    Br J Haematol; 2000 Dec; 111(4):1116-7. PubMed ID: 11227093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic relevance of monosomy at the 13q14 locus detected by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
    Hogan WJ; Tefferi A; Borell TJ; Jenkins R; Li CY; Witzig TE
    Cancer Genet Cytogenet; 1999 Apr; 110(2):77-81. PubMed ID: 10214353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Implications of Monosomies in Patients With Multiple Myeloma.
    Shin SY; Eom HS; Sohn JY; Lee H; Park B; Joo J; Jang JH; Lee MN; Kim JK; Kong SY
    Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):159-164.e2. PubMed ID: 28089441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Partial deletion of chromosome 13 long arm in multiple myeloma and its clinical significance].
    Wei DL; Qin YW; Wang C; Yan SK; Gao YR; Cai Q
    Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):217-20. PubMed ID: 16624156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 13q deletion, trisomy 1q, and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma.
    Bang SM; Kim YR; Cho HI; Chi HS; Seo EJ; Park CJ; Yoo SJ; Kim HC; Chun HG; Min HC; Oh BR; Kim TY; Lee JH; Lee DS
    Cancer Genet Cytogenet; 2006 Jul; 168(2):124-32. PubMed ID: 16843102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance.
    Bernasconi P; Cavigliano PM; Boni M; Astori C; Calatroni S; Giardini I; Rocca B; Caresana M; Crosetto N; Lazzarino M; Bernasconi C
    Br J Haematol; 2002 Aug; 118(2):545-9. PubMed ID: 12139743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical characteristics and prognosis of IGH deletion in multiple myeloma.
    He H; Fu W; Jiang H; Du J; Zhou L; Zhang C; Xi H; Li R; Hou J
    Leuk Res; 2015 May; 39(5):515-9. PubMed ID: 25817540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
    Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
    Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH.
    Shaughnessy J; Tian E; Sawyer J; Bumm K; Landes R; Badros A; Morris C; Tricot G; Epstein J; Barlogie B
    Blood; 2000 Aug; 96(4):1505-11. PubMed ID: 10942398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of chromosomal abnormalities detected by interphase fluorescence in situ hybridization in newly diagnosed multiple myeloma patients.
    Hu Y; Chen L; Sun CY; She XM; Ai LS; Qin Y
    Chin Med J (Engl); 2011 Oct; 124(19):2981-5. PubMed ID: 22040539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells.
    Fiserová A; Hájek R; Holubová V; Büchler T; Sobotka J; Kovárová R; Musilová R; Bourková L; Buliková A; Mareschová I; Janácková Z; Váñová P; Kuglík P; Vorlícek J; Penka M
    Neoplasma; 2002; 49(5):300-6. PubMed ID: 12458327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China.
    Wang H; Meng H; Wang J; Lou Y; Zhou Y; Lin P; Li F; Liu L; Xu H; Yang M; Jin J
    Front Med; 2020 Jun; 14(3):327-334. PubMed ID: 31784918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes.
    Pérez-Simón JA; García-Sanz R; Tabernero MD; Almeida J; González M; Fernández-Calvo J; Moro MJ; Hernández JM; San Miguel JF; Orfão A
    Blood; 1998 May; 91(9):3366-71. PubMed ID: 9558394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.
    Schop RF; Jalal SM; Van Wier SA; Ahmann GJ; Bailey RJ; Kyle RA; Greipp PR; Rajkumar SV; Gertz MA; Lust JA; Lacy MQ; Dispenzieri A; Witzig TE; Fonseca R
    Cancer Genet Cytogenet; 2002 Jan; 132(1):55-60. PubMed ID: 11801310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myeloma.
    He J; Yang L; Meng X; Wei G; Wu W; Han X; Zheng G; Zheng W; Ye X; Shi J; Xie W; Zhang J; Huang H; Lin M; Cai Z
    Am J Med Sci; 2013 Feb; 345(2):88-93. PubMed ID: 22986611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
    Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
    Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
    Orlandi EM; Bernasconi P; Pascutto C; Giardini I; Cavigliano PM; Boni M; Zibellini S; Cazzola M
    Hematol Oncol; 2013 Sep; 31(3):136-42. PubMed ID: 23060227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.